Targeting Glucagon Pathway May Offer a New Approach to Treating Diabetes
News Category: Clinical News
04/16/2012 0 Comments Contact Our News Editors
Maintaining the right level of sugar in the blood is the responsibility not only of insulin, which removes glucose, but also of a hormone called glucagon, which adds glucose. For decades, treatments for type II diabetes have taken aim at insulin, but a new study suggests that a better approach may be to target glucagon's sweetening effect.
The findings were published April 12 in the online edition of Cell Metabolism.